Year: 2018
Type: article
Abstract: ERK2 across a variety of cell types, tissues, and species. We used our chemoproteomic strategy to determine potency and selectivity of academic (VX-11e) and clinical (Ulixertinib) ERK inhibitors. Correlation of potency estimates by chemoproteomics with anti-proliferative activity of VX-11e and Ulixertinib revealed that >90% inactivation of both native ERK1 and ERK2 is needed to mediate cellular activity of inhibitors. Our findings introduce one of the first assays capable of independent evaluation of native ERK1 and ERK2 activity to advance drug discovery of oncogenic MAPK pathways.
Source: Chemical Science
DOI: 10.1039/c8sc00043c
Authors: Myungsun Shin, Caroline E. Franks, Ku-Lung Hsu
Institutions: University of Virginia, University of Virginia Cancer Center
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: diamond
Awards: G2040153736, DIACYLGLYCEROL ACTIVATION OF T-CELL RECEPTOR SIGNALING FOR CANCER IMMUNOTHERAPY, Functional Characterization of Diacylglycerol Lipases in Mammalian Physiology, G4119534169, G4272361073, Functional Characterization of Diacylglycerol Lipases in Mammalian Physiology, G5850682332, Training in the Pharmacological Sciences, Diacylglycerol Activation of T-Cell Receptor Signaling for Cancer Immunotherapy, G9000260557, Endocannabinoid Biosynthesis in Inflammation and Pain
OpenAlex ID: W2787283083
